DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 207 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,947,528 | -6.4% | 2,704,917 | -28.9% | 1.36% | -17.7% |
| Q1 2023 | $37,330,680 | -7.8% | 3,805,370 | 0.0% | 1.65% | +13.7% |
| Q4 2022 | $40,489,137 | +1.9% | 3,805,370 | 0.0% | 1.45% | +0.9% |
| Q3 2022 | $39,728,000 | -17.1% | 3,805,370 | 0.0% | 1.44% | -21.4% |
| Q2 2022 | $47,910,000 | +16.1% | 3,805,370 | 0.0% | 1.83% | +18.5% |
| Q1 2022 | $41,250,000 | -23.0% | 3,805,370 | 0.0% | 1.54% | -15.4% |
| Q4 2021 | $53,542,000 | -15.1% | 3,805,370 | +15.9% | 1.82% | -1.7% |
| Q3 2021 | $63,077,000 | +114.1% | 3,283,570 | +9.8% | 1.86% | +101.0% |
| Q2 2021 | $29,459,000 | -14.1% | 2,990,770 | -14.3% | 0.92% | -11.9% |
| Q1 2021 | $34,314,000 | +162.5% | 3,490,770 | +18.9% | 1.05% | +127.8% |
| Q4 2020 | $13,070,000 | +3.0% | 2,936,990 | 0.0% | 0.46% | -21.6% |
| Q3 2020 | $12,688,000 | +25.1% | 2,936,990 | +156.8% | 0.59% | +11.6% |
| Q2 2020 | $10,143,000 | – | 1,143,526 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |